Use este identificador para citar ou linkar para este item:
http://hdl.handle.net/1843/51519| Tipo: | Artigo de Periódico |
| Título: | Lyophilized symbiotic mitigates mucositis induced by 5-fluorouracil |
| Autor(es): | Bruna Machado Savassi Bárbara Fernandes Cordeiro Sara Heloisa da Silva Emiliano Rosa Oliveira Giovanna Belo Alessandra Gomes Figueiroa Maria Izabel Alves Queiroz Ana Maria Caetano Faria Juliana Alves Tales Fernando da Silva Gabriela Munis Campos Erick Almeida Esmerino Ramon da Silva Rocha Mônica Queiroz de Freitas Marcia Cristina Silva Adriano Gomes da Cruz Kátia Duarte Vital Simone Odília Antunes Fernandes Valbert Nascimento Cardoso Leonardo Borges Arcucio Gwénaël Jan Yves Le Loir Alfonso Gala-Garcia Fillipe Luiz Rosa do Carmo Vasco Azevedo |
| Resumo: | Mucositis is an adverse effect of cancer chemotherapies using 5-Fluorouracil (5-FU). It is characterized by mucosal inflammation, pain, diarrhea, and weight loss. Some studies reported promising healing effects of probiotic strains, when associated with prebiotics, as adjuvant treatment of mucositis. We developed a lyophilized symbiotic product, containing skimmed milk, supplemented with whey protein isolate (WPI) and with fructooligosaccharides (FOS), and fermented by Lactobacillus casei BL23, Lactiplantibacillus plantarum B7, and Lacticaseibacillus rhamnosus B1. In a mice 5-FU mucositis model, this symbiotic lyophilized formulation was able to reduce weight loss and intestinal permeability. This last was determined in vivo by quantifying blood radioactivity after oral administration of 99mTc-DTPA. Finally, histological damages caused by 5-FU-induced mucositis were monitored. Consumption of the symbiotic formulation caused a reduced score of inflammation in the duodenum, ileum, and colon. In addition, it decreased levels of pro-inflammatory cytokines IL-1β, IL-6, IL-17, and TNF-α in the mice ileum. The symbiotic product developed in this work thus represents a promising adjuvant treatment of mucositis. |
| Assunto: | Mucosite 5-Fluorouracil Probiótico Prebiótico |
| Idioma: | eng |
| País: | Brasil |
| Editor: | Universidade Federal de Minas Gerais |
| Sigla da Instituição: | UFMG |
| Departamento: | FAR - DEPARTAMENTO DE ALIMENTOS FAR - DEPARTAMENTO DE ANÁLISES CLÍNICAS E TOXICOLÓGICAS ICB - DEPARTAMENTO DE BIOQUÍMICA E IMUNOLOGIA |
| Tipo de Acesso: | Acesso Aberto |
| Identificador DOI: | 10.3389/fphar.2021.755871 |
| URI: | http://hdl.handle.net/1843/51519 |
| Data do documento: | 10-Dez-2021 |
| metadata.dc.url.externa: | https://www.frontiersin.org/articles/10.3389/fphar.2021.755871/full |
| metadata.dc.relation.ispartof: | Frontiers in Pharmacology |
| Aparece nas coleções: | Artigo de Periódico |
Arquivos associados a este item:
| Arquivo | Descrição | Tamanho | Formato | |
|---|---|---|---|---|
| Lyophilized Symbiotic Mitigates Mucositis Induced by 5-Fluorouracil.pdf | 3.59 MB | Adobe PDF | Visualizar/Abrir |
Os itens no repositório estão protegidos por copyright, com todos os direitos reservados, salvo quando é indicado o contrário.